上市公司独立董事提名人声明与承诺 提名人华邦生命健康股份有限公司现就提名 商光明 为山东凯盛新材料股份有限公司第四届董事会独立董事候 选人发表公开声明。被提名人已书面同意作为山东凯盛新 材料股份有限公司第四届董事会独立董事候选人（参见该 独立董事候选人声明）。本次提名是在充分了解被提名人职 业、学历、职称、详细的工作经历、全部兼职、有无重大失 信等不良记录等情况后作出的，本提名人认为被提名人符 合相关法律、行政法规、部门规章、规范性文件和深圳证券 交易所业务规则对独立董事候选人任职资格及独立性的要 求，具体声明并承诺如下事项： 一、被提名人已经通过山东凯盛新材料股份有限公司 第三届董事会第三次独立董事专门会议的资格审查，提名 人与被提名人不存在利害关系或者其他可能影响独立履职 情形的密切关系。 √ 是 □ 否 如否，请详细说明： 二、被提名人不存在《中华人民共和国公司法》第一 百七十八条等规定不得担任公司董事的情形。 √ 是 □ 否 如否，请详细说明： 1 ______________________________ ______________________________ 三、被提名人符合中国证监会《上 ...

上市公司独立董事候选人声明与承诺 声明人__魏福禄__作为山东凯盛新材料股份有限公司 第四届董事会独立董事候选人，已充分了解并同意由提名 人华邦生命健康股份有限公司提名为山东凯盛新材料股份 有限公司（以下简称该公司）第四届董事会独立董事候选人。 现公开声明和保证，本人与该公司之间不存在任何影响本 人独立性的关系，且符合相关法律、行政法规、部门规章、 规范性文件和深圳证券交易所业务规则对独立董事候选人 任职资格及独立性的要求，具体声明并承诺如下事项： 一、本人已经通过山东凯盛新材料股份有限公司独立 董事专门会议资格审查，提名人与本人不存在利害关系或 者其他可能影响独立履职情形的密切关系。 √ 是 □ 否 1 _____________________________ 如否，请详细说明： 二、本人不存在《中华人民共和国公司法》第一百七 十八条等规定不得担任公司董事的情形。 √ 是 □ 否 如否，请详细说明： 三、本人符合中国证监会《上市公司独立董事管理办 法》和深圳证券交易所业务规则规定的独立董事任职资格 和条件。 √ 是 □ 否 如否，请详细说明： 四、本人符合该公司章程规定的独立董事任职条件。 √ 是 □ 否 ...

1、股东会届次：2025 年第一次临时股东会。 | 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-029 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 2、股东会的召集人：公司董事会。 山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第三十二 次会议于 2025 年 6 月 13 日召开，会议审议通过了《关于召开 2025 年第一次临 时股东会的议案》。 3、会议召开的合法、合规性： 山东凯盛新材料股份有限公司 关于召开2025年第一次临时股东会的通知公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、召开会议的基本情况 本次股东会的召集和召开符合《中华人民共和国公司法》《上市公司股东会 规则》等法律、法规、规范性文件及《公司章程》《股东会议事规则》的有关规 定。 4、会议召开的日期、时间： （1）现场会议召开时间：2025 年 6 月 30 日（星期一）下午 14:00； （2）网络投票时间：2025 年 6 月 30 日。其中，通过深圳证券交易所交易 系统进行网络投 ...

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-026 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 山东凯盛新材料股份有限公司 第三届董事会第三十二次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、会议召开及议案审议情况 山东凯盛新材料股份有限公司（以下简称"公司"）第三届董事会第三十二 次会议通知于 2025 年 6 月 10 日以电子邮件的形式发出，2025 年 6 月 13 日于公 司会议室通过"现场+通讯"的方式召开，公司 9 名董事都参加了本次会议，会 议的通知及召开符合《公司法》及《公司章程》的规定，合法有效。本次会议由 董事长王加荣先生主持，经与会各位董事认真讨论研究，审议并通过了以下议案： （一）会议以 9 票赞成、0 票反对、0 票弃权的表决结果审议通过了《关于 修订<公司章程>的议案》 为进一步规范公司治理，公司根据中国证监会《关于新<公司法>配套制度规 则实施相关过渡期安排》相关要求，按照《中华人民共和国公司法》《上市公司 章程指引（2025 ...

Group 1: Company Performance and Market Demand - The company's PEKK product output and shipment volume have been increasing since its launch, with applications in various sectors including general profiles, coatings, new energy vehicles, and aerospace [1] - In 2025, the demand from the agricultural chemical sector has increased, leading to improved overall business performance [2] - The first quarter of 2025 saw a year-on-year and quarter-on-quarter increase in revenue and net profit, primarily due to rising demand from the agricultural chemical sector and increased product margins [2] Group 2: Financial and Operational Updates - The company has received authorization from the 2024 annual general meeting to decide on the 2025 interim profit distribution based on actual operating performance and retained earnings [2] - Specific details regarding the fundraising projects and new factory output can be found in the company's annual report and special report on fundraising usage [2] Group 3: Product Comparison and Advantages - PEKK and PEEK are both polyaryletherketone polymers with some functional similarities, but PEKK offers adjustable melting temperatures and lower production costs compared to PEEK [3] - PEKK's molecular structure provides greater rigidity and slower crystallization speed, reducing the risk of cracking during coating production [3]

| 证券代码：301069 | 证券简称：凯盛新材 公告编号：2025-025 | | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net）；或关注微信公众号（名称：全景财经）；或下载全景 路演APP,参与本次互动交流。活动时间为2025年5月15日（周四）15:00-16:30。 届时公司董事、副总经理、董事会秘书王荣海先生及证券事务代表杨紫光先生将 在线就公司 2024 年度及 2025 年第一季度业绩、公司治理、发展战略、经营状况 等投资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告。 董 事 会 山东凯盛新材料股份有限公司 关于参加 2025 年山东辖区上市公司投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 为进一步加强与投资者的互动交流，山东凯盛新材料股份有限公司（以下简 称"公司"）将参加由山东证监局、山东上市公司协会与深圳市全景网络有限公 司联合举 ...

Market Performance - The Shanghai Composite Index and Shenzhen Component Index experienced declines of 0.30% and 0.69% respectively on May 5, 2025, while the ChiNext Index and STAR Market 50 fell by 0.87% and 1.96% respectively [1] - Among 33 A-share companies in Zibo, 30 saw an increase, 1 remained flat, and 2 declined during the same period [1] Notable Stock Movements - Weiming Pharmaceutical (002581) achieved a remarkable 23.29% increase over five days, leading the gains [1] - Yahua Electronics (301337) and Jincheng Pharmaceutical (300233) also saw significant increases of 17.30% and 11.31% respectively [1] - On May 7, PEEK material concept stocks surged, with Zhongxin Fluorine Materials (002915) hitting the daily limit for the sixth time in nine days, and Kaisheng New Materials (301069) rising by 2.29% with a trading volume of 4.02 billion yuan [1] Company Announcements - Kehui Co., Ltd. announced a share repurchase plan with a budget between 9 million and 16 million yuan, with a maximum repurchase price of 17 yuan per share, aimed at employee stock ownership plans [1] Financial Results - Furuida (600223) reported a revenue of 526 million yuan in its cosmetics segment for Q1 2025, with a gross margin of 61.06% [3] - Qichang Tenda (002408) achieved total revenue of 5.618 billion yuan in Q1 2025, a year-on-year increase of 2.53%, but saw a significant drop in net profit by 83.18% to 5.4007 million yuan [3] - Xinhua Medical (600587) reported a total revenue of 2.308 billion yuan, down 8.74% year-on-year, with a net profit decline of 23.97% to 160 million yuan [3] - Bohui Paper (600966) reported a total revenue of 4.564 billion yuan, a 3.77% increase year-on-year, but a net profit decline of 46.91% to 53.3737 million yuan [3] Market Capitalization - In terms of market capitalization, Yingke Medical (300677) led with 14.708 billion yuan, followed closely by Shandong Pharmaceutical Glass (600529) at 14.626 billion yuan, and Qichang Tenda (002408) at 12.963 billion yuan [4]

Group 1 - The PEEK materials concept increased by 1.75%, ranking first among concept sectors, with 15 stocks rising, including Kent Shares, New Han New Materials, and Zhongxin Fluorine Materials, which rose by 12.97%, 12.38%, and 5.24% respectively [1][2] - The concept sector experienced a net outflow of 254 million yuan, with 12 stocks receiving net inflows, led by New Han New Materials with a net inflow of 55.99 million yuan, followed by Kent Shares, Nanjing Julong, and Kaisheng New Materials [2][3] - The net inflow ratios for Kent Shares, New Han New Materials, and Kaisheng New Materials were 12.82%, 6.67%, and 4.93% respectively, indicating strong interest from main funds [3] Group 2 - The top gainers in the PEEK materials sector included Kent Shares and New Han New Materials, while the top losers were Shuanglin Shares, Tian Ci Materials, and Chaojie Shares, which fell by 2.58%, 2.05%, and 1.79% respectively [1][4] - The trading volume and turnover rates for leading stocks in the PEEK materials sector were significant, with New Han New Materials having a turnover rate of 29.71% and Kent Shares at 28.03% [3][4] - The overall market performance showed a mixed trend, with various sectors experiencing both gains and losses, highlighting the volatility in the current market environment [2][4]

Core Viewpoint - Solid-state battery additives are crucial materials for enhancing battery performance, such as ionic conductivity and interface stability, with a comprehensive ranking based on technology routes, production capacity, and market performance. Group 1: LiFSI (Lithium bis(fluorosulfonyl)imide) Sector - Ruifai New Materials ranks among the top three global LiFSI producers, with a production capacity exceeding 10,000 tons by 2025, suitable for high-voltage solid-state battery requirements. The purity reaches 99.9%, and costs are 15% lower than traditional lithium hexafluorophosphate. The company has supplied to CATL and BYD for solid-state battery projects [1]. - Limin Co., Ltd. has extended its technology through its subsidiary Zhuobang New Energy, ranking among the top three in LiFSI production capacity, suitable for high-safety scenarios like robotics and flying cars [2]. - The customer network of Limin Co., Ltd. includes leading battery companies such as CATL and Tesla, with overseas orders expected to grow by 85% in 2024 [3]. Group 2: Sulfide Electrolyte Precursors - Tianci Materials is the largest electrolyte liquid company globally, extending LiFSI technology to sulfide electrolyte precursors, with costs 44% lower than Japanese competitors. By 2025, LiFSI production capacity will expand to 20,000 tons, supporting sulfide all-solid-state battery production lines [5]. - Tianci Materials holds over 60% market share in the global sulfide precursor market, with a binding relationship with Yunnan Germanium for raw materials. The ionic conductivity of sulfide electrolytes reaches 10 mS/cm, with costs 40% lower than similar Japanese products [5]. - The market share of zirconium oxychloride exceeds 50%, compatible with both oxide and sulfide dual technology routes, with samples sent to leading companies like Qingtai Energy. By 2025, zirconium-based material production capacity will reach 20,000 tons, covering key raw material needs for electrolytes [5]. Group 3: Chlorosulfonic Acid (LiFSI Raw Material) - Shilong Industrial has a cost advantage, with chlorosulfonic acid production costs 20% lower than the industry average, having entered the supply chains of Tianci Materials and Ruifai New Materials [6]. Group 4: Other Key Additives - Longpan Technology and Aoke Co., Ltd. have achieved a production capacity of 5,000 tons/year for solvent-based additives for solid-state batteries, suitable for optimizing sulfide electrolyte interfaces [7]. Group 5: Potential Enterprises - Daoshi Technology is focusing on conductive agents (carbon nanotubes) and silicon-carbon negative electrode additives, catering to the high energy density requirements of solid-state batteries [8]. - Guanghua Technology is developing lithium salts (LiTFSI) and composite additives to enhance the cycle life of solid-state batteries [9]. Group 6: Industry Leaders - Kaisheng New Materials is the largest chlorosulfonic acid supplier globally, with a production capacity exceeding 100,000 tons/year and a market share over 40%. The purity reaches electronic grade (99.999%), suitable for solid-state battery electrolyte synthesis [12]. - The company possesses a technical barrier, being one of the few globally to master full-solid-state compatible additive technology, with a projected market share growth to 18% in 2024. Key clients include CATL and Tesla, with plans to double production capacity by 2025 [13].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002004 证券简称：华邦健康公告编号：2025025 华邦生命健康股份有限公司 2025年3月20日，公司获得深圳证券交易所出具的《关于华邦生命健康股份有限公司非公开发行科技创 新可交换公司债券符合深交所挂牌条件的无异议函》（深证函〔2025〕249号）。详见公司于2025年3月 21日在巨潮资讯网（http://www.cninfo.com.cn）等指定信息披露媒体上披露的《关于收到〈关于华邦生 命健康股份有限公司非公开行科技创新可交换公司债券符合深交所挂牌条件的无异议函〉的公告》（公 告编号：2025005）。 截至2025年4月22日，公司面向专业投资者非公开发行可交换公司债券已发行完成，本次可交换债券的 相关信息如下： 4、换股期：自本期可交换公司债券发行结束之日满6个月后的第一个交易日起至本期可交换公司债券到 期日前一交易日止。 特此公告。 华邦生命健康股份有限公司 董事会 2025年4月24日 关于非公开发行可交换公司债券发行完成的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 ...